NEW YORK (GenomeWeb News) – Molecular diagnostics developer Metamark Genetics has appointed Gregory Critchfield, Mansoor Raza Mirza, and Slava Smolokowski to serve on its board of directors. Critchfield formerly was president of Myriad Genetics Laboratories. Mirza is chief oncologist at the Finsen Centre at Copenhagen University Hospital, and Smolokowski is an entrepreneur and an investor in Metamark.
Gregory Critchfield also has been named to the board of directors at Saladax Biomedical. Before he worked at Myriad, Critchfield held several senior positions within the industry, including as senior vice president and chief medical and science officer at Corning Clinical Laboratory/Quest Diagnostics.
Vermillion has appointed Jeffrey Salzman to be corporate director of reimbursement. Salzman previously was director of health plans and payor markets at Ipsogen, and he worked for nine years at Quest Diagnostics as an executive in health planning.
Current Rosetta Genomics Chief Scientific Officer Dalia Cohen will take over the CSO post at Asterand, the research services company said this week. Cohen will lead scientific positioning and strategy at Asterand. Before working with Rosetta Genomics, she was global head of functional genomics at Novartis Pharmaceuticals.
Stanley Lapidus has resigned his post as chairman of Helicos BioSciences but will remain a member of the board of directors. Helicos' board elected Ivan Trifunovich to serve as a member of the company's board and simultaneously appointed him executive chairman of the board. Trifunovich previously served as SVP of Third Wave Technologies, prior to that firm's acquisition by Hologic. He also had held management positions as Pharmacia and Johnson & Johnson.
Molecular Response has tapped Cyrus Mirsaidi to take over the CEO position. Mirsaidi spent a decade at Nichols Institute Diagnostics, where he was responsible for global launch of clinical diagnostic IVD tests and automated platforms. He also was GM and executive director at Ontogen, and he was VP at AltheaDx, where he worked on licensing efforts with pharmaceutical partners.
GenomeQuest has appointed Richard Wilson, a professor of genetics and director of The Cancer Genome Center at Washington University School of Medicine, to its Science Advisory Board.
Wilson is an expert in molecular genetics and large-scale DNA sequence analysis, and his lab at Washington University is focused on using genome sequencing and analysis technologies to improve diagnosis and treatment of cancer.
Patrick Sullivan has been appointed to Gen-Probe's board of directors. Sullivan is the former president, CEO, and chairman of Cytyc Corporation, and he now leads Constitution Medical Investors.
National Institute of General Medical Sciences Director Jeremy Berg has won the Howard K. Schachman Public Service Award from the American Society for Biochemistry and Molecular Biology. The annual award is given to recognize exemplary dedication to public service in support of biomedical science.
The American Society of Human Genetics has named Jurg Ott its 2010 William Allan Award Winner. Ott is professor emeritus of the Laboratory of Statistical Genetics at Rockefeller University. He was given the award in honor of his work involving statistical approaches for detecting linkage and association of loci for complex diseases, which are used in genome-wide association studies.
BGI Americas has named Julia Dan as CEO and Paul Tu as president. Previously, Dan was a co-founder and managing partner of NuCure Bioscience and senior manager of Sepracor's commercial group. Dan also served as the business development manager at Genzyme, where she led the company's efforts to set up commercial operations in Beijing.
Tu also was a co-founder and managing partner of NuCure Bioscience, and previously a principal at venture capital firm MTDC. He has also served as vice president in the commercial lending division at Eastern Bank.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.